APA ציטוט

Kim, Y. H., Fukuhara, A., & Mishima, M. (2011). Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease? S. Karger AG.

Citação norma Chicago

Kim, Young Hak, Akiko Fukuhara, and Michiaki Mishima. Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued Beyond Progressive Disease? S. Karger AG, 2011.

ציטוט MLA

Kim, Young Hak, Akiko Fukuhara, and Michiaki Mishima. Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued Beyond Progressive Disease? S. Karger AG, 2011.